These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Value of gated SPECT myocardial perfusion imaging for individual cardiac risk assessment]. Nowak B Z Kardiol; 2005; 94 Suppl 4():IV/81-84. PubMed ID: 16416071 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of radionuclide exercise testing after myocardial infarction. Schocken DD Cardiol Clin; 1984 Aug; 2(3):391-401. PubMed ID: 6399870 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis and risk stratification in coronary artery disease: nuclear cardiology versus stress echocardiography. Bonow RO J Nucl Cardiol; 1997; 4(2 Pt 2):S172-8. PubMed ID: 9115081 [TBL] [Abstract][Full Text] [Related]
26. Myocardial perfusion scintigraphy as an aid in understanding electrocardiographic changes of ischemia and infarction. Zaret BL; Wackers FJ Ann N Y Acad Sci; 1990; 601():107-18. PubMed ID: 2221682 [TBL] [Abstract][Full Text] [Related]
27. Risk stratification after myocardial infarction in the thrombolytic era. Rutherford JD Curr Opin Cardiol; 1996 Jul; 11(4):428-33. PubMed ID: 8879954 [TBL] [Abstract][Full Text] [Related]
28. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Ladenheim ML; Kotler TS; Pollock BH; Berman DS; Diamond GA Am J Cardiol; 1987 Feb; 59(4):270-7. PubMed ID: 3812276 [TBL] [Abstract][Full Text] [Related]
29. Radionuclide angiography for risk stratification of patients with coronary artery disease. Bonow RO Am J Cardiol; 1993 Sep; 72(9):735-9. PubMed ID: 8249854 [TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular nuclear medicine 1976/'06: 30 years representation in clinical cardiology]. Bavelaar-Croon CD; Slart RH; Bax JJ; van der Wall EE Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1373-9. PubMed ID: 16841584 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of coronary artery disease in women. Miller DD Curr Opin Cardiol; 1996 Jul; 11(4):447-53. PubMed ID: 8879957 [TBL] [Abstract][Full Text] [Related]
32. Prognosis and diagnostic work-up in patients admitted for, but without, myocardial infarction--the value of nuclear medicine examinations. Launbjerg J; Fruergaard P; Jørgensen FB; Madsen JK; Hesse B Clin Physiol; 1990 May; 10(3):273-7. PubMed ID: 2350943 [TBL] [Abstract][Full Text] [Related]
34. Silent myocardial ischemia: II. Prognosis and implications for the clinical assessment of patients with coronary artery disease. Rozanski A; Berman DS Am Heart J; 1987 Sep; 114(3):627-38. PubMed ID: 3307362 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of cardiovascular nuclear medicine exercise studies. Rozanski A; Berman DS Semin Nucl Med; 1987 Apr; 17(2):104-20. PubMed ID: 3296196 [TBL] [Abstract][Full Text] [Related]
36. Nuclear medicine studies of the heart. Bengel FM; Schwaiger M Eur Radiol; 1998; 8(9):1698-706. PubMed ID: 9866791 [TBL] [Abstract][Full Text] [Related]
37. Role of nuclear cardiology for determining management of patients with stable coronary artery disease. Gibbons RJ J Nucl Cardiol; 1994; 1(5 Pt 2):S118-30. PubMed ID: 9420737 [TBL] [Abstract][Full Text] [Related]
38. Assessment of stable ischemic heart disease. Which tests are best for which patients? Lavie CJ; Ventura HO; Murgo JP Postgrad Med; 1991 Jan; 89(1):44-50, 57-60, 63. PubMed ID: 1985319 [TBL] [Abstract][Full Text] [Related]
39. Myocardial perfusion imaging versus biochemical markers in acute coronary syndromes. Anand DV; Lahiri A Nucl Med Commun; 2003 Oct; 24(10):1049-54. PubMed ID: 14508160 [TBL] [Abstract][Full Text] [Related]
40. The prognostic value of myocardial perfusion imaging in patients with suspected or known coronary artery disease. Reyes E; Anagnostopoulos C Nucl Med Commun; 2004 Mar; 25(3):217-20. PubMed ID: 15094437 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]